SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-215774
Filing Date
2021-07-15
Accepted
2021-07-15 06:45:37
Documents
14
Period of Report
2021-07-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d192734d8k.htm   iXBRL 8-K 24885
2 EX-99.1 d192734dex991.htm EX-99.1 13542
6 GRAPHIC g192734g0714200730422.jpg GRAPHIC 3577
  Complete submission text file 0001193125-21-215774.txt   170988

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sybx-20210715.xsd EX-101.SCH 2915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20210715_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20210715_pre.xml EX-101.PRE 11423
7 EXTRACTED XBRL INSTANCE DOCUMENT d192734d8k_htm.xml XML 3366
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 211091648
SIC: 2834 Pharmaceutical Preparations